Thus, we speculated that increased CCNL1, DNAJB1, DUSP6, and EFNB2 inhibited the MAPK pathway in cSCC, and they were potential PDT target genes in cSCC treatment. This evidence concerns the gene EFNB2 and skin squamous cell carcinoma.